142 related articles for article (PubMed ID: 1722079)
1. Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells.
Biron KK; de Miranda P; Burnette TC; Krenitsky TA
Antimicrob Agents Chemother; 1991 Oct; 35(10):2116-20. PubMed ID: 1722079
[TBL] [Abstract][Full Text] [Related]
2. Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.
de Miranda P; Burnette TC; Biron KK; Miller RL; Averett DR; Krenitsky TA
Antimicrob Agents Chemother; 1991 Oct; 35(10):2121-4. PubMed ID: 1662024
[TBL] [Abstract][Full Text] [Related]
3. 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
Averett DR; Koszalka GW; Fyfe JA; Roberts GB; Purifoy DJ; Krenitsky TA
Antimicrob Agents Chemother; 1991 May; 35(5):851-7. PubMed ID: 1649571
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ
Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679
[TBL] [Abstract][Full Text] [Related]
5. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
Verhoef V; Fridland A
Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098
[TBL] [Abstract][Full Text] [Related]
6. Metabolic disposition and pharmacokinetics of the antiviral agent 6-methoxypurine arabinoside in rats and monkeys.
Burnette TC; Koszalka GW; Krenitsky TA; De Miranda P
Antimicrob Agents Chemother; 1991 Jun; 35(6):1165-73. PubMed ID: 1929259
[TBL] [Abstract][Full Text] [Related]
7. Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus.
Miller RL; Iltis JP; Rapp F
IARC Sci Publ (1971); 1978; (24 Pt 2):991-7. PubMed ID: 221418
[TBL] [Abstract][Full Text] [Related]
8. Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.
Soike KF; Felsenfeld AD; Gibson S; Gerone PJ
Antimicrob Agents Chemother; 1980 Jul; 18(1):142-7. PubMed ID: 6158291
[TBL] [Abstract][Full Text] [Related]
9. Retinal toxicity of 6-methoxypurine arabinoside (ara-M). A new selective and potent inhibitor of varicella-zoster virus.
Karaçorlu S; Peyman GA; Karaçorlu M; Dunlap W; Soike KF
Retina; 1992; 12(3):261-4. PubMed ID: 1329170
[TBL] [Abstract][Full Text] [Related]
10. 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.
Koszalka GW; Averett DR; Fyfe JA; Roberts GB; Spector T; Biron K; Krenitsky TA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1437-43. PubMed ID: 1656862
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
[TBL] [Abstract][Full Text] [Related]
12. Interaction of arabinosyl nucleotides in K562 human leukemia cells.
Gandhi V; Plunkett W
Biochem Pharmacol; 1989 Oct; 38(20):3551-8. PubMed ID: 2479383
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
Balzarini J; McGuigan C
Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside.
Bryson YJ; Connor JD
Antimicrob Agents Chemother; 1976 Mar; 9(3):540-3. PubMed ID: 176937
[TBL] [Abstract][Full Text] [Related]
15. 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies.
Lambe CU; Averett DR; Paff MT; Reardon JE; Wilson JG; Krenitsky TA
Cancer Res; 1995 Aug; 55(15):3352-6. PubMed ID: 7614470
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
Yokota T; Konno K; Shigeta S; Verbruggen A; De Clercq E
Mol Pharmacol; 1987 May; 31(5):493-9. PubMed ID: 3033468
[TBL] [Abstract][Full Text] [Related]
17. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
Yokota T; Konno K; Shigeta S; De Clercq E
Mol Pharmacol; 1984 Sep; 26(2):376-80. PubMed ID: 6090888
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of oxetanocins against varicella-zoster virus.
Sakuma T; Saijo M; Suzutani T; Yoshida I; Saito S; Kitagawa M; Hasegawa S; Azuma M
Antimicrob Agents Chemother; 1991 Jul; 35(7):1512-4. PubMed ID: 1656865
[TBL] [Abstract][Full Text] [Related]
19. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
20. High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine.
McCann WP; Hall LM; Siler W; Barton N; Whitley RJ
Antimicrob Agents Chemother; 1985 Aug; 28(2):265-73. PubMed ID: 2423028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
